Also on Trial Friend:Myelodysplastic Syndromes pageMatch Me
All 287 Myelodysplastic Syndromes trials and their US sites
Enter your ZIP code above to sort them by how far their nearest open site is from you.
- MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)Most sites in Illinois, Wisconsin and CaliforniaRecruitingPhase 2Ages 18+National Cancer Institute (NCI)332US sites
44 states - Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)Most sites in Illinois, Minnesota and MichiganRecruitingPhase 2Ages 18-59National Cancer Institute (NCI)202US sites
40 states - The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group StudyMost sites in Texas, Florida and CaliforniaRecruitingPhase 1/2Up to age 22PedAL BCU156US sites
47 states - Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)Most sites in Illinois, Minnesota and IowaRecruitingPhase 2Ages 18+National Cancer Institute (NCI)145US sites
30 states - SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryMost sites in California, New York and MarylandRecruitingMassive Bio67US sites
40 states - Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).Most sites in Washington, California and New YorkRecruitingPhase 3Ages 18+Ascentage Pharma Group40US sites
24 states - A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood TransfusionsMost sites in Texas, Florida and New YorkRecruitingPhase 3Ages 18+Takeda35US sites
20 states - A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)Most sites in Florida, Maryland and North CarolinaRecruitingPhase 1/2Ages 12+Sumitomo Pharma America30US sites
18 states - Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and AnemiaMost sites in California, Florida and New YorkRecruitingPhase 1/2Ages 18+Disc Medicine29US sites
19 states - A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood TransfusionsMost sites in Texas, California and FloridaRecruitingPhase 3Ages 18+Takeda25US sites
15 states - A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)Most sites in New York, California and OregonRecruitingPhase 2/3Ages 18+Taiho Oncology22US sites
15 states - Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic SyndromesMost sites in Missouri, New Jersey and New YorkRecruitingPhase 1Ages 18+National Cancer Institute (NCI)20US sites
9 states - A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to TherapyMost sites in California, Pennsylvania and AlabamaRecruitingPhase 1Ages 1-18Children's Oncology Group18US sites
16 states - CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)Most sites in Florida, New York and CaliforniaRecruitingPhase 1/2Ages 18+Cullinan Therapeutics15US sites
10 states - A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic SyndromesMost sites in Maryland, Ohio and CaliforniaRecruitingPhase 2Ages 18+Akeso14US sites
12 states - A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell TransplantationMost sites in California, Alabama and FloridaRecruitingPhase 2Ages 18-66Center for International Blood and Marrow Transplant Research13US sites
12 states - A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic SyndromeMost sites in California, Florida and New YorkRecruitingPhase 1Ages 18+BlossomHill Therapeutics13US sites
9 states - Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)Most sites in California, Ohio and TexasRecruitingPhase 1/2Ages 18+Rigel Pharmaceuticals13US sites
9 states - A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid LeukemiasMost sites in California, Tennessee and FloridaRecruitingPhase 1Ages 12+Crossbow Therapeutics11US sites
9 states - Collection of Tissue Samples for Cancer ResearchMost sites in Maryland, Georgia and IndianaRecruitingAges 2 Months+National Cancer Institute (NCI)10US sites
9 states
New trials, status changes and new sites, straight from ClinicalTrials.gov. Unsubscribe anytime.
- Trial Alerts, when a new trial opens or a trial changes
- Disease Updates, FDA decisions and condition news, usually 1 or 2 emails a month
Who runs the Myelodysplastic Syndromes trials in the US, and what stage they are in
Of the 196 Myelodysplastic Syndromes trials with a US site, 6 are in Phase 3, the last stage before a company can ask the FDA for approval. Earlier Phase 1 or 2 tests of safety and dosing make up 158 of them. The remaining 32 have no drug phase, such as studies that follow people over time or test a device or a way of giving care. Companies run 46 of them, and universities, hospitals, foundations and government groups run 150. The sponsors with the most are M.D. Anderson Cancer Center (22), National Cancer Institute (NCI) (11) and Fred Hutchinson Cancer Center (10). The most recently listed one first appeared on ClinicalTrials.gov on November 2, 2026.
Myelodysplastic Syndromes trials in the US, state by state
Of the 196 Myelodysplastic Syndromes trials with a US site, 53 accept children under 18. Their open sites are in 48 states and Washington, DC, most often New York, Texas and California. A trial counts once in each state where it has an open site, and some trials accept both children and adults.
Show the other 40 states
US hospitals running the most Myelodysplastic Syndromes trials
Centers that run trials for a rare condition often see more people with it than most clinics do, so this list can also help you find doctors who know Myelodysplastic Syndromes.
- M D Anderson Cancer CenterHouston, Texas18 trials
- Moffitt Cancer CenterTampa, Florida16 trials
- Dana-Farber Cancer InstituteBoston, Massachusetts14 trials
- MD Anderson Cancer CenterHouston, Texas14 trials
- City of Hope Medical CenterDuarte, California13 trials
- Memorial Sloan Kettering Cancer CenterNew York, New York13 trials
- Fred Hutch/University of Washington Cancer ConsortiumSeattle, Washington11 trials
- National Institutes of Health Clinical CenterBethesda, Maryland10 trials
- Washington University School of MedicineSt Louis, Missouri10 trials
- City of HopeDuarte, California9 trials
Help getting to a Myelodysplastic Syndromes trial far from home
Ask the study team whether the trial pays back travel, parking and hotel costs, because many sponsors do. The FDA's guidance on paying research volunteers says paying back these costs does not count as pressuring someone to join.
These nonprofits also help patients reach care, and each one sets its own rules.
- Mercy Medical Angels
- Pays for gas cards, ground rides and airline tickets anywhere in the US, and it lists clinical trials as a reason to travel. Household income at or below 300% of the federal poverty guidelines, and usually a trip of 50 miles or more each way.
- Air Charity Network
- Volunteer pilots in all 50 states fly patients for free in small private planes, and members also fly people taking part in clinical trials. You must be able to walk and sit upright for the flight, show financial need and have a backup plan if weather cancels it.
- Corporate Angel Network
- Puts cancer patients in empty seats on business jets for treatment, second opinions and clinical trials. Open to anyone with cancer who can walk and travel without medical help, and it does not check income.
- American Cancer Society Hope Lodge
- Offers a free place to stay at 31 Hope Lodge locations for people getting cancer treatment far from home. People facing cancer and their caregivers, when treatment is far from home.
- Ronald McDonald House
- Gives families a room near the hospital while a child gets care, through 394 House programs around the world. Families of a sick child, with rules set by each local chapter.
- Healthcare Hospitality Network
- Keeps a map of hospitality houses near hospitals, and most member houses charge little or nothing to patients and families. Each house sets its own rules, so check with the house near your study site.
Program details were checked on each program's website on October 24, 2026.
Questions about finding a Myelodysplastic Syndromes trial near you
Are there Myelodysplastic Syndromes clinical trials near me?
As of November 13, 2026, 287 Myelodysplastic Syndromes clinical trials are recruiting now and 51 are not yet recruiting. In the US, 196 of them have at least 1 open site, across 49 states and Washington, DC. Enter your ZIP code on this page to rank every one of them by the distance to its closest open site, with the sites shown on a map.
Which states have Myelodysplastic Syndromes clinical trial sites?
Recruiting Myelodysplastic Syndromes trials list open sites in 49 states and Washington, DC. Texas, California and New York have the most, and the table on this page lists every state.
Are there Myelodysplastic Syndromes trials for children near me?
Of the 196 Myelodysplastic Syndromes trials with a US site, 53 accept children under 18. Their open sites are in 48 states and Washington, DC, most often New York, Texas and California. Each trial sets its own age limits, so check the ages listed on a trial before you contact it.
Who pays for travel to a Myelodysplastic Syndromes clinical trial?
Many trial sponsors pay back travel, parking and hotel costs, so ask the study team before you rule out a far-away site. The FDA's guidance says paying back these costs does not count as pressuring someone to join. Charities such as Mercy Medical Angels and Air Charity Network can also help with rides and flights, and Corporate Angel Network flies cancer patients for free.
What if there is no Myelodysplastic Syndromes trial near me?
Some trials send staff to your home or use a local lab, so fewer visits happen at the study site. You can also sign up on this page to get an email when a Myelodysplastic Syndromes trial opens a new site or changes status.
How is the distance to a trial site measured?
Distances are straight-line miles from the center of your ZIP code to each study site's listed location, not driving distance. Your browser looks up the ZIP code's coordinates with a free map service, Zippopotam.us, and the ZIP code is never sent to or stored by Trial Friend.
FDA-approved for Myelodysplastic Syndromes: Inqovi (decitabine and cedazuridine), Rytelo (imetelstat), Decitabine (decitabine (injection)), Grafapex (treosulfan), Reblozyl (luspatercept-aamt), Revlimid (lenalidomide), Tibsovo (ivosidenib), Vidaza (azacitidine (injection)).
Clinical trials near you for related conditions
Source: ClinicalTrials.gov, trials with status Recruiting or Not yet recruiting. Refreshed every 6 hours; counts as of November 13, 2026. Sites that ClinicalTrials.gov lists as closed or withdrawn are left out. Children means the trial's age group includes people under 18.